Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toronto Research Chemicals (TRC) is a leading manufacturer and supplier of complex organic chemicals for biomedical research. Founded in 1982, the company specializes in providing high-quality specialized chemicals, including analytical standards, impurities, metabolites, and labeled compounds for the pharmaceutical and biotechnology industries. TRC offers a vast catalog of over 350,000 products used in drug discovery, forensic science, and environmental analysis. In 2019, the company was acquired by LGC Group, further expanding its global reach and integration into the clinical and diagnostic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on research chemical companies.